Impact of CMS coverage decision on access to transcatheter aortic valve replacement
Brian O’Neill(Henry Ford Health System), Mauro Moscucci(Alaska Heart and Vascular Institute), Mauricio G. Cohen(Santa Ana College), Conrad Macon(Oregon Health & Science University), Claudia Martinez, Alan W. Heldman(University of Miami), Pascal Goldschmidt Clermont(University of Miami Hospital), Pedro Martinez Clark(University of Miami), David Seo(University of Miami), Carlos E. Alfonso(University of Miami), William W. O’Neill(Henry Ford Health System), Donald Williams(University of Miami Hospital), Omaida Velasquez(University of Miami Hospital)
Cited by 5
Related Papers
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k
A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
|New England Journal of Medicine|1987|945